<DOC>
	<DOCNO>NCT00005821</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure sentinel lymph node biopsy may improve ability detect breast cancer determine extent disease . PURPOSE : Phase II trial study effectiveness sentinel lymph node biopsy ass axillary lymph node woman stage I stage II breast cancer .</brief_summary>
	<brief_title>Sentinel Lymph Node Biopsy Assess Axillary Lymph Nodes Women With Stage I Stage II Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare sentinel node biopsy v axillary dissection determine axillary nodal status woman resectable stage I II breast cancer . OUTLINE : Patients stratify accord node status ( positive v negative ) . Patients undergo lymphoscintigraphy , consist technetium Tc 99m human serum albumin colloid inject near tumor . Dynamic image use gamma camera perform 20 minute postinjection static image obtain 3 hour postinjection . Surgery perform within 24 hour lymphoscintigraphy . Patients injected patent blue V dye near tumor gamma detection probe use measure radioactive count sentinel node . Surgery begin within 5 minute patent blue V dye injection . All lymph node stain blue high radioactive count remove . The primary breast lump remove either wide local excision mastectomy axilla clear standard axillary dissection . Some patient may receive patent blue V dye inject pilot study . Sentinel lymph node biopsy axillary dissection proceed . PROJECTED ACCRUAL : A total 150 patient ( 75 per stratum ) accrue main study plus another 50 patient pilot study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis stage I II invasive breast cancer triple assessment : Clinically Mammogram and/or ultrasound Fine needle cytology Resectable disease either wide local excision mastectomy axillary dissection No ductal carcinoma situ Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 Sex : Female Menopausal status : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant No known allergy vital blue dye No mental illness handicap would preclude study entry No severe illness would preclude study participation PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2003</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
</DOC>